Washington DC

Customs and Border Protection

 

 

Recent Advocacy

  • AIPLA Comments on Inventorship Guidance for AI-Assisted Inventions

    May 15, 2024

    Arlington, VA. May 10, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO in response to the Inventorship Guidance for AI-Assisted Inventions.
  • AIPLA Comments to USPTO on Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace

    May 14, 2024

    Arlington, VA. May 14, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments in response to the USPTO’s Request for Comment regarding Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace.
  • AIPLA Files Amicus Brief in REGENXBIO Inc. v. Sarepta Therapeutics, Inc.

    May 14, 2024

    Arlington, VA. May 10, 2024 - The American Intellectual Property Law Association (AIPLA) filed an amicus brief in support of neither party with the Court of Appeals for the Federal Circuit in REGENXBIO Inc. v. Sarepta Therapeutics, Inc., a case on appeal from the U.S. District Court for the District of Delaware. The district court held that cultured host cells containing a recombinant nucleic acid molecule were not eligible for patent protection under Section 101 of the Patent Act because the individual nucleic acid sequences used in the recombinant molecule were not modified or changed from their naturally occurring state.